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Abstract In this report, we study Ca2+ transport in permeabi-
lized Candida parapsilosis spheroplasts prepared by a new
technique using lyticase. An intracellular non-mitochondrial
Ca2+ uptake pathway, insensitive to orthovanadate and sensitive
to the V-H+-ATPase inhibitor bafilomycin A1, nigericin and
carbonyl cyanide p-trifluoromethoxyphenylhydrazone was char-
acterized. Acidification of the compartment in which Ca2+
accumulated was followed using the fluorescent dye acridine
orange. Acidification was stimulated by the Ca2+ chelator EGTA
and inhibited by Ca2+. These results, when added to the
observation that Ca2+ induces alkalization of a cellular
compartment, provide evidence for the presence of a Ca2+/nH+
antiporter in the acid compartment membrane. Interestingly, like
in acidocalcisomes of trypanosomatids, the antioxidant 3,5-
dibutyl-4-hydroxytoluene inhibits the V-H+-ATPase. In addi-
tion, the antifungal agent ketoconazole promoted a fast
alkalization of the acidic compartment. Ketoconazole effects
were dose-dependent and occurred in a concentration range close
to that attained in the plasma of patients treated with this
drug. ß 2001 Published by Elsevier Science B.V. on behalf of
the Federation of European Biochemical Societies.
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1. Introduction
The incidence of severe fungal infections has increased dur-
ing the last decades [1,2] and fungal infections have become a
major cause of mortality among imunocompromised patients,
including those with AIDS [2^4]. Disturbingly, frequent re-
ports that fungi are developing resistance to antifungal agents
have surfaced [4,5]. In oncological patients, Candida albicans
accounted for 54% and Candida parapsilosis for 7% of all
systemic Candida infections [4]. Current chemotherapy against
these parasites has many £aws, including low speci¢city, tox-
icity and drug resistance [1]. It is, therefore, very important to
search for biological targets in these parasites that could be
exploited for the rational development of improved therapies.
In this search, understanding of the mechanisms involved in
fungal control of Ca2 homeostasis is very important, since
disruption of Ca2 homeostasis leads to cell death [8]. Cell
death is also intimately linked to energetic metabolism, and
we have recently characterized aspects of C. parapsilosis en-
ergy conservation systems [7].
Intracellular Ca2 ions play a crucial role in controlling
many biological processes [9] which are dependent on Ca2
compartmentalization, governed by several transport systems
operating in a highly regulated fashion [9]. Cells have devel-
oped a variety of molecular devices, such as channels, pumps
and transporters, to regulate Ca2 in£ux and e¥ux across the
plasma membrane and between intracellular stores, adjusting
cytoplasmic Ca2 concentrations [9]. Mammalian cells contain
very active Ca2-ATPases and Ca2/Na antiporters in their
plasma membrane, able to promote the fast exchange of intra-
cellular Ca2 with the extracellular pool. In contrast, most
Ca2 transport into and out of the cytoplasm of fungal cells
is mediated by their vacuolar membranes [13]. Vacuoles are
the largest compartments in yeast cells and are postulated to
function as lysosomes and storage compartments [10]. In most
plant and fungal cells, the vacuoles occupy over 50% of the
cell volume and their membrane contains numerous carriers,
transporters, channels and enzymes. Little is known about the
mechanisms involved in Ca2 homeostasis in C. parapsilosis,
which is assumed to transport Ca2 in a manner similar to
Saccharomyces cerevisiae [11].
In this report we demonstrate that C. parapsilosis possesses
a non-mitochondrial, nigericin-sensitive Ca2 compartment
that functions in a manner dependent on the pH gradient
formed by a ba¢lomycin A1-sensitive H-ATPase. A Ca2/
nH antiporter apparently mediates Ca2 uptake and release
by this acidic compartment. Furthermore, ketoconazole, an
antimycotic drug, promotes a fast and extensive alkalization
of the acidic compartment, followed by Ca2 release.
2. Materials and methods
2.1. C. parapsilosis culture
C. parapsilosis CCT 3834 (ATCC 22019) cells were cultured at 37‡C
under vigorous aeration in complete liquid medium (2% glycerol, 2%
Bacto-peptone (Difco), 1% Bacto-yeast extract (Difco) until the mid-
exponential phase.
2.2. Spheroplast preparation
Cultured C. parapsilosis cells were harvested by centrifugation from
a liter of culture media, and cells were washed with cold water, fol-
lowed by a wash using bu¡er A (1 M sorbitol, 10 mM MgCl2 and 50
mM Tris^HCl, pH 7.8). Cells were resuspended in bu¡er A (3 ml/g of
cells) containing 30 mM dithiothreitol (DTT). After 15 min incuba-
tion at room temperature with shaking, cells were harvested by cen-
trifugation, resuspended in bu¡er A containing lyticase (1 mg/g of
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cells) and 1 mM DTT and incubated at 30‡C until approximately 90%
of the cells converted to spheroplasts (60^80 min). The digestion was
stopped by the addition of an equal volume of ice-cold bu¡er A, and
spheroplasts were washed twice with the same bu¡er. Protein concen-
tration of the ¢nal suspension was determined using the biuret assay
[14] in the presence of 0.2% deoxycolate.
2.3. Measurement of Ca2+ movements
Variations in free Ca2 concentrations were followed by measuring
the changes in the absorbance spectrum of arsenazo III [15], using a
SLM Aminco DW 2000 spectrophotometer at the wavelength pair
675^685 nm [16,17]. The concentrations of the ionic species and com-
plexes at equilibrium were calculated by employing an interactive
computer program as described before [18].
2.4. Proton pump activity
Acidi¢cation of permeabilized cells was followed by measuring the
changes in the absorbance or £uorescence spectrum of acridine orange
(AO) [19], using a SLM Aminco DW2000 spectrophotometer at the
wavelength pair 493^530 nm or a Hitachi F4500 £uorescence spectro-
photometer at the wavelength pair 510^550 nm.
Each experiment was repeated at least three times with di¡erent cell
preparations, and the ¢gures show representative experiments.
2.5. Chemicals
ATP, calcium ionophore A23187, sodium orthovanadate, carbonyl
cyanide p-tri£uoromethoxyphenylhydrazone (FCCP), succinate, ar-
senazo III, EGTA, nigericin, antimycin A, myxothiazol, oligomycin,
ammonium chloride and lyticase were purchased from Sigma. AO was
from Molecular Probes (Eugene, OR, USA). All other reagents were
of analytical grade.
3. Results
3.1. Ca2+ uptake by C. parapsilosis spheroplasts: inhibition by
nigericin and ba¢lomycin A1
Fig. 1 shows that, when C. parapsilosis spheroplasts were
added to a reaction medium containing MgATP, succinate
and 8 WM free Ca2, most of the Ca2 present was taken
up and retained by the spheroplasts. The subsequent addition
of the Ca2 ionophore A23187 promoted a release of the accu-
mulated cation [trace (a)]. Nigericin, a K/H exchanger, was
also able to release part of the accumulated Ca2 [trace (c)].
The simultaneous presence of antimycin A, oligomycin and
myxothiazol (see [7]), which prevent mitochondrial energiza-
tion and Ca2 uptake [21] or sodium orthovanadate, an in-
hibitor of the P-type Ca2-ATPase, caused no di¡erence either
on the rate or extent of Ca2 uptake (the trace is superimpos-
able with trace (a)). The presence of a V-H-PPase [22] in
these vacuoles was also ruled out in our experiments.
Acidic compartments may possess an ATP-driven H pump
that maintains their interior at a pH lower than that of the
cytoplasm [20]. These H pumps are ba¢lomycin A1-sensitive
[21,23]. Indeed, trace (b) shows that when C. parapsilosis
spheroplasts were added to reaction medium containing niger-
icin or ba¢lomycin A1, Ca2-transport activity was completely
inhibited (the traces with ba¢lomycin A1 and nigericin are
superimposable). The sensitivity of this Ca2-transporting ac-
tivity to ba¢lomycin A1 con¢rms that Ca2 is being taken up
by a compartment acidi¢ed by a V-type proton ATPase [24].
3.2. ATP-dependent vacuolar acidi¢cation in C. parapsilosis
spheroplasts: e¡ects of nigericin, NH4Cl and
ba¢lomycin A1
In order to con¢rm the presence of a V-H-ATPase in these
cells we used AO, a tertiary amine that becomes concentrated
in acidic compartments and changes both its absorbance and
£uorescence properties as a consequence of its stacking [19] as
a probe. Trace (a) shows that the addition of ATP to a re-
action medium containing antimycin A, myxothiazol, oligo-
mycin, EGTA and C. parapsilosis spheroplasts caused a sig-
ni¢cant time-dependent decrease in the absorbance of AO
compatible with its accumulation in acidic compartments.
This uptake was inhibited by ba¢lomycin A1 [trace (c)]. The
addition of ba¢lomycin A1 also reversed the decrease in AO
absorbance [trace (b)]. EGTA, present in trace a, decreased
the concentration of Ca2 from 8 WM to less than 1 nM and
stimulated both the rate and extent of AO absorbance de-
crease, when compared to trace (b). Under all experimental
conditions tested, nigericin, FCCP or NH4Cl reversed the
decrease in AO absorbance induced by ATP, con¢rming
that the decrease in AO absorbance was caused by its accu-
mulation into acidic compartments.
3.3. Calcium-induced AO release from C. parapsilosis acidic
vacuoles
We also investigated the e¡ect of Ca2 on the C. parapsi-
losis ATP-dependent compartment acidi¢cation, in a reaction
medium containing antimycin A, myxothiazol and oligomy-
cin. Fig. 3 shows that 40 WM CaCl2 [trace (b)] reversed the
decrease in AO absorbance promoted by the spheroplasts.
Fig. 1. Ca2 uptake by C. parapsilosis spheroplasts. The C. parapsilosis spheroplasts (1 mg of protein/ml) were added to standard reaction me-
dia (125 mM sucrose, 65 mM KCl, 10 mM HEPES, pH 7.2, 2.5 mM potassium phosphate, 1 mM Mg Cl2) containing 5 mM succinate, 40 WM
arsenazo III and 0.5 mM ATP. Trace (a), control; trace (b), 1.3 WM nigericin and/or 2.5 WM ba¢lomycin A1 present from the beginning of the
experiment and trace (c), 1.3 WM nigericin added where indicated. Calcium ionophore A23187 (1 WM) was added where indicated by the arrow.
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Addition of 20 mM NH4Cl completed the release of AO. This
AO release induced by Ca2 also occurs when vanadate was
present in the incubation medium, indicating that this process
is totally independent of cation transport by a P-type Ca2-
ATPase [trace (a)]. Furthermore, the presence of 20 WM
EGTA, which removes most of the contaminant Ca2 present
in the reaction medium (about 8 WM), increased the extent of
ATP-dependent vacuolar acidi¢cation in the permeabilized
cells [trace (a)], indicating a close relationship between Ca2
uptake and vacuolar acidi¢cation. Both the insensitivity of
Ca2 uptake to vanadate (Fig. 1) and the vacuolar alkaliza-
tion promoted by this cation (Fig. 2 traces (a) and (b)) suggest
the presence of a Ca2/nH antiporter in the vacuoles of these
cells [11,12]. The stimulation of AO uptake by EGTA (Fig. 2)
and its release by Ca2 (Fig. 3) indicate that this dye and Ca2
are, in fact, being accumulated in the same compartment.
3.4. E¡ect of 3,5-dibutyl-4-hydroxytoluene (BHT) on ATP-
driven AO accumulation by C. parapsilosis spheroplasts
We have previously demonstrated [29] that BHT, at com-
monly used antioxidant concentrations [25], has an inhibitory
e¡ect on both V-H-ATPases and Na/H antiporters of the
acidocalcisomes present in Trypanosoma brucei procyclic try-
pomastigotes. At the same concentration, and depending on
the preincubation time, BHT presented a stimulatory or in-
hibitory e¡ect on the vacuolar H-ATPase present in those
trypanosomes [29].
In Fig. 4 we studied the e¡ects of di¡erent concentrations of
BHT on AO uptake in C. parapsilosis spheroplasts. When
ATP was added 30 s after BHT was included in the medium,
a progressive inhibition of AO accumulation was detected
with increasing BHT concentrations (5^20 WM) [traces (b^d)].
3.5. Vacuole alkalization by the antimycotic drug ketoconazole
Ketoconazole (R41.400; Janssen Pharmaceutica) is an imi-
dazole derivative with broad-spectrum activity against fungi
and pathogenic yeast [26]. It is proposed that ketoconazole
and other azole-based antimycotic agents (£uconazole, itraco-
nazole) act by inhibiting the synthesis of ergosterol, the pre-
dominant component of the fungal cell membrane [27].
Since Ca2-containing vacuoles are not present in most
mammalian cells, they can be exploited as important targets
for drugs against diseases caused by fungi. In this regard, we
studied the e¡ect of the antimycotic drug ketoconazole [28] on
the retention of AO by the acidic vacuoles in C. parapsilosis
(Fig. 5). Ketoconazole (16^128 Wg/ml, 75^600 nM) induced a
progressive alkalization of the acidocalcisome [traces (b^e)].
As expected, this was followed by Ca2 release (not shown).
Fig. 2. ATP-driven AO accumulation by C. parapsilosis sphero-
plasts. The spheroplasts (1 mg of protein/ml) were added to the
standard reaction media containing 2 WM antimycin A, 2 Wg/ml oli-
gomycin, and 2 Wg/ml myxothiazol. AO (3.3 WM) was added 3 min
after the cells. Trace (a), EGTA (1 mM) present in the reaction me-
dia; trace (b), 4 WM ba¢lomycin A1 added where indicated by the
arrow and trace (c), ba¢lomycin A1 (4 WM, from the beginning of
the experiment) or absence of ATP (traces were superimposable).
ATP (0.5 mM), 20 mM NH4Cl, 1 WM FCCP and 1.3 WM nigericin
were added where indicated.
Fig. 3. Ca2 e¡ect on ATP-driven AO accumulation in C. parapsilo-
sis spheroplasts. The spheroplasts (1 mg of protein/ml) were added
to standard reaction media containing 2 WM antimycin A, 2 Wg/ml
oligomycin, 2 Wg/ml myxothiazol and 20 WM EGTA. AO (3.3 WM)
was added 3 min after the cells. ATP (0.5 mM), 40 WM CaCl2 and
20 mM NH4Cl were added where indicated. Trace (a), 400 WM
vanadate present from the beginning of the experiment and trace
(b), control.
Fig. 4. Inhibition by BHT of ATP-driven AO accumulation in C.
parapsilosis spheroplasts. The spheroplasts (1 mg of protein/ml)
were added to the standard reaction medium containing 2 WM anti-
mycin A, 2 Wg/ml oligomycin, 2 Wg/ml myxothiazol and 1 mM
EGTA. AO (3.3 WM) was added 3 min after the cells. ATP (0.5
mM) and 1.3 WM nigericin were added where indicated. BHT was
added 30s before ATP. Trace (a), control; trace (b), 5 WM BHT;
trace (c), 10 WM BHT; trace (d), 20 WM BHT.
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The concentration range studied was the same used in drug
susceptibility tests, with the di¡erence that the cell concentra-
tion used in these experiments was at least three orders of
magnitude higher than that used in these tests [6]. Other
azole-based antimycotic agents, such as £uconazole and itra-
conazole, had no e¡ect on the retention of AO by the acidic
vacuoles.
4. Discussion
This study demonstrates that lyticase can be used to pre-
pare C. parapsilosis spheroplasts, permeable to ions, nucleo-
tides and respiratory substrates, without a¡ecting the func-
tional integrity of their internal vacuoles. Previous results [7]
demonstrated that the functional properties of their mitochon-
dria are also preserved after this treatment.
Our experiments provide strong evidence for the presence of
acidic Ca2 storage vacuoles in C. parapsilosis. First, we dem-
onstrate inhibition and release of Ca2 by the K/H iono-
phore nigericin and the vacuolar H-ATPase inhibitor ba¢lo-
mycin A1 (Fig. 1). Also using permeabilized spheroplasts, we
show that Ca2 induces alkalization of the intracellular
vesicles, as measured by shifts in AO £uorescence (Fig. 2).
The mitochondrial inhibitors used (antimycin A, myxothiazol
and oligomycin) had no e¡ect on Ca2 uptake by these per-
meabilized cells, suggesting that mitochondria, although able
to carry out oxidative phosphorylation and other energy-
linked functions [7], are not actively participating in Ca2
homeostasis. The inhibition of Ca2 uptake by the vacuolar
H-ATPase inhibitor ba¢lomycin A1 (Fig. 1) indicates that
the internal acidic pH generated by the vacuolar proton
pump promotes Ca2 uptake and retention. Furthermore,
EGTA, which decreases medium Ca2 concentration (Fig.
2), increased the rate of ATP-dependent vacuolar acidi¢cation
in C. parapsilosis spheroplasts, again indicating a close rela-
tionship between Ca2 uptake and vacuolar acidi¢cation. The
insensitivity of Ca2 uptake to orthovanadate indicates that
this transport is not mediated by a P-type Ca2-ATPase and
that this enzyme is not present in these vacuoles where Ca2
movements seem to be mediated by a Ca2/nH antiporter,
dependent on Ca2 and pH gradients.
The possible physiological roles of this integrated system
for Ca2 and H transport (H-ATPase and Ca2/nH)
could be many: regulation of cytosolic Ca2 concentration,
a large-scale Ca2 storage system to provide a homeostatic
reserve, or a detoxi¢cation system to prevent the e¡ects of
excess free Ca2 in the cytosol when the cells are submitted
to an unfavorable environment. Alternatively, the regulation
of cytosolic pH could be very important in many physiolog-
ical situations. In many microorganisms, relatively small in-
creases in cytosolic pH halt cell division and activate the ex-
pression of di¡erent genes [37]. On the other hand, increases
in cytosolic Ca2, mediated by Ca2 in£ux through the plas-
ma membrane, could induce H release from the acidic vac-
uoles, protecting the cells against alkaline pH.
We have previously reported [29] that the antioxidant BHT
has e¡ects on both H-ATPases and Na/H antiporters
from T. brucei. These e¡ects are not related to alterations in
the £uidity or viscosity of the bilayer, as expected with a
hydrophobic molecule [35]. Using C. parapsilosis spheroplasts,
we also demonstrated an inhibitory e¡ect of BHT (Fig. 4),
which is probably due to its e¡ect on the H-ATPase, since
we could not detect a Na/H antiporter in these cells.
Acidic vacuoles containing Ca2 have been previously de-
scribed in Dictyostelium discoideum [30], trypanosomatids
[31,34,38] and some mammalian cells [32,33], although this
¢nding is controversial [36]. The acidic vacuole in C. para-
psilosis could represent a potential target for the chemother-
apy against this fungus. In this regard, the antimycotic drug
ketoconazole promoted a fast alkalization of these vacuoles
(Fig. 5) that, in addition to its e¡ect on the synthesis of er-
gosterol [39], could be involved in the mechanism of its anti-
mycotic action. This is a new and singular e¡ect described for
ketoconazole, since the other two azole-based antimycotic
agents tested (£uconazole and itraconazole) had no e¡ect on
the C. parapsilosis acidic vacuole. Although all these com-
pounds inhibit ergosterol synthesis [39], there is a heterogene-
ity of action among them and ketoconazole is the only drug
known to have e¡ects on several membrane-bound enzymes
[39], a property which seems to be in agreement with its
unique e¡ect on the acidic vacuole of C. parapsilosis. In this
regard, WM concentrations of ketoconazole can be detected in
the plasma of patients using therapeutic doses of this drug
[40]. The Ca2-containing C. parapsilosis acid vacuoles seem
to be similar to those present in plant cells [24] and di¡er from
those present in most trypanosomatids [22] because they lack
Ca2-ATPase, V-H-PPase and Na/H exchanger.
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